Gut mycobiome as a promising preventive and therapeutic target for metabolic disorders
-
Published:2022-03
Issue:
Volume:13
Page:100168
-
ISSN:2589-9368
-
Container-title:Metabolism Open
-
language:en
-
Short-container-title:Metabolism Open
Author:
Dalamaga MariaORCID,
Zheng Liaoyuan,
Liu Junli
Reference20 articles.
1. Gut microbiota in human metabolic health and disease;Fan;Nat Rev Microbiol,2021
2. Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence;Vallianou;Curr Obes Rep,2021
3. Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives;Dalamaga;Curr Obes Rep,2020
4. Understanding the role of the gut microbiome and microbial metabolites in obesity and obesity-associated metabolic disorders: current evidence and perspectives;Vallianou;Curr Obes Rep,2019
5. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era;Dalamaga;Semin Cancer Biol,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献